These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 26367780)

  • 1. Solid lipid nanoparticles (SLN) of Efavirenz as lymph targeting drug delivery system: Elucidation of mechanism of uptake using chylomicron flow blocking approach.
    Makwana V; Jain R; Patel K; Nivsarkar M; Joshi A
    Int J Pharm; 2015 Nov; 495(1):439-446. PubMed ID: 26367780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lopinavir loaded solid lipid nanoparticles (SLN) for intestinal lymphatic targeting.
    Aji Alex MR; Chacko AJ; Jose S; Souto EB
    Eur J Pharm Sci; 2011 Jan; 42(1-2):11-8. PubMed ID: 20971188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solid lipid nanoparticles of diethylcarbamazine citrate for enhanced delivery to the lymphatics: in vitro and in vivo evaluation.
    Siram K; Chellan VR; Natarajan T; Krishnamoorthy B; Mohamed Ebrahim HR; Karanam V; Muthuswamy SS; Ranganathan HP
    Expert Opin Drug Deliv; 2014 Sep; 11(9):1351-65. PubMed ID: 24847779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved anti-hyperlipidemic activity of Rosuvastatin Calcium via lipid nanoparticles: Pharmacokinetic and pharmacodynamic evaluation.
    Dudhipala N; Veerabrahma K
    Eur J Pharm Biopharm; 2017 Jan; 110():47-57. PubMed ID: 27810472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solid lipid nanoparticles as vesicles for oral delivery of olmesartan medoxomil: formulation, optimization and in vivo evaluation.
    Nooli M; Chella N; Kulhari H; Shastri NR; Sistla R
    Drug Dev Ind Pharm; 2017 Apr; 43(4):611-617. PubMed ID: 28005442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic Approach for the Formulation and Optimization of Solid Lipid Nanoparticles of Efavirenz by High Pressure Homogenization Using Design of Experiments for Brain Targeting and Enhanced Bioavailability.
    Gupta S; Kesarla R; Chotai N; Misra A; Omri A
    Biomed Res Int; 2017; 2017():5984014. PubMed ID: 28243600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An oral formulation of efavirenz-loaded lactoferrin nanoparticles with improved biodistribution and pharmacokinetic profile.
    Kumar P; Lakshmi YS; Kondapi AK
    HIV Med; 2017 Aug; 18(7):452-462. PubMed ID: 28000390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation, in vitro evaluation and statistical optimization of carvedilol-loaded solid lipid nanoparticles for lymphatic absorption via oral administration.
    Shah MK; Madan P; Lin S
    Pharm Dev Technol; 2014 Jun; 19(4):475-85. PubMed ID: 23697916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation, optimization, characterization and in vivo pharmacokinetic study of asiatic acid tromethamine salt-loaded solid lipid nanoparticles.
    Lingling G; Yuan Z; Weigen L
    Drug Dev Ind Pharm; 2016 Aug; 42(8):1325-33. PubMed ID: 26821124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting of AIDS related encephalopathy using phenylalanine anchored lipidic nanocarrier.
    Vyas A; Jain A; Hurkat P; Jain A; Jain SK
    Colloids Surf B Biointerfaces; 2015 Jul; 131():155-61. PubMed ID: 25988279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and in vitro, in vivo evaluations of norfloxacin-loaded solid lipid nanopartices for oral delivery.
    Dong Z; Xie S; Zhu L; Wang Y; Wang X; Zhou W
    Drug Deliv; 2011 Aug; 18(6):441-50. PubMed ID: 21554156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanosuspension of efavirenz for improved oral bioavailability: formulation optimization, in vitro, in situ and in vivo evaluation.
    Patel GV; Patel VB; Pathak A; Rajput SJ
    Drug Dev Ind Pharm; 2014 Jan; 40(1):80-91. PubMed ID: 23323843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic Development of Sertraline Loaded Solid Lipid Nanoparticle (SLN) by Emulsification-Ultrasonication Method and Pharmacokinetic Study in Sprague-Dawley Rats.
    Rahman MA; Harwansh RK; Iqbal Z
    Pharm Nanotechnol; 2019; 7(2):162-176. PubMed ID: 30919786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Key production parameters for the development of solid lipid nanoparticles by high shear homogenization.
    Souto EB; Doktorovova S; Zielinska A; Silva AM
    Pharm Dev Technol; 2019 Nov; 24(9):1181-1185. PubMed ID: 31354002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation, characterization, and evaluation of gatifloxacin loaded solid lipid nanoparticles as colloidal ocular drug delivery system.
    Kalam MA; Sultana Y; Ali A; Aqil M; Mishra AK; Chuttani K
    J Drug Target; 2010 Apr; 18(3):191-204. PubMed ID: 19839712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid nanoparticles of zaleplon for improved oral delivery by Box-Behnken design: optimization, in vitro and in vivo evaluation.
    Dudhipala N; Janga KY
    Drug Dev Ind Pharm; 2017 Jul; 43(7):1205-1214. PubMed ID: 28274147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid nanoparticles for oral delivery of raloxifene: optimization, stability, in vivo evaluation and uptake mechanism.
    Ravi PR; Aditya N; Kathuria H; Malekar S; Vats R
    Eur J Pharm Biopharm; 2014 May; 87(1):114-24. PubMed ID: 24378615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimization of nimesulide-loaded solid lipid nanoparticles (SLN) by factorial design, release profile and cytotoxicity in human Colon adenocarcinoma cell line.
    Campos JR; Fernandes AR; Sousa R; Fangueiro JF; Boonme P; Garcia ML; Silva AM; Naveros BC; Souto EB
    Pharm Dev Technol; 2019 Jun; 24(5):616-622. PubMed ID: 30477410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solid lipid nanoparticles for sustained pulmonary delivery of Yuxingcao essential oil: Preparation, characterization and in vivo evaluation.
    Zhao Y; Chang YX; Hu X; Liu CY; Quan LH; Liao YH
    Int J Pharm; 2017 Jan; 516(1-2):364-371. PubMed ID: 27884712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioactive-Chylomicrons for Oral Lymphatic Targeting of Berberine Chloride: Novel Flow-Blockage Assay in Tissue-Based and Caco-2 Cell Line Models.
    Elsheikh MA; Elnaggar YSR; Otify DY; Abdallah OY
    Pharm Res; 2018 Jan; 35(1):18. PubMed ID: 29305670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.